Drug discovery of Covid 19
COVIDâ€‘19 Drug discovery is the research process to develop a preventative vaccine or therapeutic prescription drug that would alleviate the severity of 2019-20 coronavirus disease (COVIDâ€‘19). Internationally during April 2020, some 250 drug companies, biotechnology firms, university research groups, and health organizations were developing 115 vaccine candidates and 153 potential therapies for COVIDâ€‘19 disease in various stages of preclinical or clinical research.
Advances in Pharmacoepidemiology and Drug Safety always wants to be on the forefront when it comes to sharing the current research. We’d be truly gratified if you could share your exploration as a Research article, Review article, Case report, Short communication, Conference proceeding on the following special issue topic.
Special Issue guidelines
Longdom Publishing welcomes proposals for creating special issues that fall within the scope of epidemiology journals published by Longdom. The special issues should aim at exploring recent advances in designing, building, manufacturing, and other technical areas concerned with all branches of engineering. We seek original unpublished works that represent specific areas of research which can widen the scope of technological applications to all fields of Pharmacoepidemiology.
Special issues will be released on a monthly basis and proposals will be accepted accordingly. All proposals should include the following information:
- Title of the proposed special issue
- Purpose and current relevance
- List of topics to be covered
- List of potential contributors
- Guest Editor(s) and Reviewers
- Address, phone, e-mail, and fax of guest editors and reviewers
- Tentative deadlines for submission and review process (Timeline for submission, review, and final acceptance)
All proposals should be submitted to www.longdom.org/submissions/advances-pharmacoepidemiology-drug-safety.html or send as an e-mail attachment to the Editorial Office at [email protected]
Role of EB Members
- Review the special issue proposals for relevance to current research in the concerned field.
- Recommend suitable proposals and their guest editors along with their biographies.
Once a proposal has been accepted by the EB members for creating a special issue, the corresponding guest editors will be responsible for handling and processing of the special issue articles.
Role of Guest Editor(s)
- State the importance of the proposed special issue theme and explain how the special issue articles will contribute towards advancing the scope of the journal.
- Suggest potential authors and invite them for contributing relevant articles for the proposed special issue.
- Suggest a minimum of 3-5 reviewers for the manuscripts submitted towards the special issue.
- Carry out all communications with potential authors and reviewers concerning author guidelines for manuscript preparation and reviewing.
- Prepare a timeline and schedule for the release of special issue articles. This should include a timeline for manuscript preparation, review process, and final submission.
- Oversee the submission of final edited versions of the contributing articles along with the contact information of all corresponding authors.
- Include a short editorial for the topic of interest written either by the guest editor or by any of the contributors.
- Special issue articles can include both original unpublished research articles and review articles related to the specific theme.
- Manuscripts will be accepted for publishing in the special issue only after getting approved by the peer review committee [selected by the guest editor(s)].
- All the articles in special issues should strictly adhere to journal style and formatting.
- Each special issue can be created with 10-15 articles.
- All accepted manuscripts can be submitted online via www.longdom.org/submissions/advances-pharmacoepidemiology-drug-safety.html Submission should be accompanied by a cover letter with reference to the concerned special issue theme.
- Accepted manuscripts submitted before the deadline will be published within the given timeframe for the respective journal publication.
Once accepted and published, all special issues will be released under an open access system through Longdom Publishing and will be freely available for reading, downloading, and printing.
For further information on special issue guidelines and submission process, please contact [email protected]